|
3rd Annual Pharma Pricing, Reimbursement & Market Access 2019
“Critical guide for successfully identifying your pricing, reimbursement and market access strategies”
29th & 30th October 2019, Hotel TBC, Washington, DC, USA
3rd Annual Pharma Pricing, Reimbursement & Market Access 2019 will provide an overview of global pricing, market access systems and cost management techniques, as well as in-depth discussion of some of the most current trends and changes. This Conference will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry.
CONFERENCE DELEGATE REGISTRATION:
In order to register please let us know your interests to E-mail - [email protected] Tel: +44 2036120886
Please note that this is a PAID event and NOT A FREE event (no complimentary passes available). Any invite, email or tickets issued mentioning it as a free pass or free ticket to this event through any third party site will strictly not be accepted by the organizer and entry won’t be granted at the event.
• Super Early Bird Price – £799 per Delegate (Valid Till 12th August 2019)
• Early Bird Price – £999 per Delegate (Valid Till 13thAugust - 23rd September 2019)
• Standard Price – £1199 per Delegate (From 24th September 2019 onwards)
CONFERENCE SPONSORSHIP:
E-mail - [email protected] in Tel: +44 2036120886
Sponsor, Exhibition Stall (Booth) and a paid Speaker Slots are also available.
We also have some sponsorship opportunities available for the event, which gives you an opportunity to sponsor/speak/exhibit, and create brand awareness. In addition, the networking opportunities in focused and relevant industry gathering provide the personal contact necessary for business development efforts.
KEY SPEAKERS:
• ROBERT POPOVIAN, SR. Director, US Government Relations, Pfizer
• SHANTHY KRISHNARAJAH, Senior Director, Global Health Economics & Reimbursement Strategy, CSL Behring
• BEHZAD MADHAVI, VP Strategic Innovation & Alliances, Lonza
• JENNIFER WONG, Senior Director, Real World Evidence Strategy & Alliances, AstraZeneca
• MARTIN ROST, Senior Director, Market Access (Global), Pfizer
• KRISTINA HARTER, Director, New Product Planning, Boston Pharmaceuticals
• MATTHEW HURLBURT, Global Access Transformation Lead, Pfizer
• RICHARD LINER, Senior Compliance Counsel, Bayer
• ALEEN HOSDAGHIAN, Sr. Director of Marketing, Sun Pharma
• GARY ELLEXSON, VP Corporate Accounts, Supernus Pharmaceuticals
• BOXIONG TANG, Sr. Director, BeiGene
• HEATHER LEIGH FLANNERY, Global Lead, ConsenSys Health
• MICHAEL THOMPSON, President & CEO, National Alliance of Healthcare Purchaser Coalitions
• SUSAN THORNTON, CEO, Cutaneous Lymphoma Foundation
• EVERETT CROSLAND, VP of Market Access & Reimbursement, AppliedVR
• MELVA COVINGTON, Senior Director, EVERSANA, Health Economics and Outcomes Research
• REED STEPHENS, Partner-In-Charge Washington, D.C. Health Industry Advisory Group, McDermott Will & Emery
• SAIRA SULTAN, President & CEO, Connect 4 Strategies
Plus more joining soon
WHO SHOULD ATTEND:
Senior Vice Presidents, Vice Presidents, Senior Executives, Global Heads, Heads, Directors, Senior Managers, Managers of
Pricing, Reimbursement, Market Access, Commercial Pricing, Pricing Strategists, Health Economics, Outcomes Research, Regulatory Affairs, Governmental Affairs, Public Affairs, Public Policy Directors, Operations, Governmental bodies, Regulatory bodies.
KEY THEMES:
• Preparing your best market access strategy
• EU and US policy challenges for market access: Stepping ahead
• Unrivalled opportunity to expose and address the market access challenges facing the industry
• Current & future - Challenges & opportunities in pharma pricing, reimbursement & market access
• Improving patient and market access through the development of targeted value propositions, comprehensive contract assessment
• Measurement strategies through to in-depth knowledge regarding payer formulary coverage trends
• How can payers and industry work together to ensure that innovative and valuable treatments make it to the market?
• Understanding - payers’ perspective
• Advocating and collaborating with payers for value in a new era
• Creating a robust patient services and reimbursement support program for biosimilar products
• Prioritising Patients! - Adding value through an innovative patient-centered approach
• Understand how price affects market access and learn on how to set prices for optimal access and returns.
• New drugs are failing to gain reimbursement from payers/HTAs at an alarming rate, despite being approved by regulators
• Evidence Generation - The strategic rigor and creativity applied to evidence generation
• Impact of social media and digital analytics
• Developing risk-sharing reimbursement models and value based pricing
• Patient engagement and adherence within the environment
• Explaining how to use the data sources and observational research for effective safety analysis
• Dwell ahead of regulatory developments & improving your strategies in a cost effective way Accelerating new medicine introduction in developing world & overcoming challenges
• Be part of a major networking opportunity
Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.
|
